Top Stories

Waymo, the self-driving car unit of Google parent Alphabet Inc. (GOOG, GOOGL), said Wednesday that it has officially launched its first driverless-car service, Waymo One, in Arizona. The company added that as self-driving technology is new to many...


After reporting strong job growth in the previous month, the Labor Department released a report Friday morning showing employment in the U.S. increased by much less than expected in the month of November. The report said non-farm payroll employment...


A US appeals court ruled against an order President Donald Trump issued last month that denies asylum pleas of migrants who crossed the southern border illegally. Two members of the three-judge bench of the 9th US Circuit Court of Appeals said late...


After fluctuating early in the session, stocks moved sharply lower over the course of the trading day on Friday. The major averages showed a substantial move back to the downside following the rebound from early weakness seen in the previous session.


Kevin Hart, who was selected to host the next Academy Awards ceremony, has relieved himself from the role following a controversy over some homophobic tweets he made years ago. The American comedian, actor and producer made the announcement Friday...

asian-up_02dec18.jpg Asian stock markets are in positive territory Monday on improved risk appetite after U.S. President Donald Trump and Chinese President Xi Jinping agreed to a 90-day truce on their escalating trade war by halting additional tariffs as the two countries continue negotiations. The U.S. has agreed to leave tariffs on more than $200 billion worth of Chinese products at 10 percent on January 1.
cannabisleaf-nov19.jpg Medical marijuana dispensaries have opened for the first time in Iowa on Saturday, December 1, 2018. Five medical cannabidiol or CBD dispensaries have opened for business in Sioux City, Council Bluffs, Windsor Heights, Waterloo and Davenport. MedPharma Iowa, Iowa's only medical cannabidiol manufacturer, will manufacture all of the state's legal marijuana products in Des Moines.
pharma-020718_03dec18.jpg Today's Daily Dose brings you news about miRagen's phase I trial results of Cobomarsen in mycosis fungoides patients; MEDALIST trial results; Apellis Pharma's paroxysmal nocturnal hemoglobinuria study results; Blueprint Medicines' EXPLORER trial results, and Celyad's progress in phase I trial of non-gene edited allogeneic CAR-T therapy.
stockmarkets-aug17_03dec18.jpg European stocks are set to open sharply higher on Monday after the U.S. and Chinese presidents agreed to a temporary truce in the clash between the world's two largest economies. U.S. President Donald Trump promised to suspend new tariffs on Chinese...
Read More
heather-nauert-120718.jpg Confirming numerous media reports, President Donald Trump announced plans to nominate State Department spokeswoman Heather Nauert as U.S. Ambassador to the United Nations on Friday. Trump revealed his intention to nominate Nauert as UN Ambassador in brief remarks to reporters on the south lawn of the White House.
Read More
us-capitol-120618.jpg With a potential government shutdown looming, members of Congress voted Thursday to approve a short-term spending bill amid an ongoing disagreement over funding for President Donald Trump's proposed border wall. The two-week spending bill extends funding for several government agencies.
Read More
Shares of Aphria Inc. tumbled more than 23 percent in Tuesday's regular trading on the New York Stock Exchange after a short seller called the Canada-based medical cannabis company a "black hole" and alleged that the company's recent Latin American acquisitions appeared to be largely worthless. In response to the allegations, Aphria said it believes the short-seller report is malicious.
Read More
A collection of the popular stories from the cryptocurrency and blockchain space this week. Read More
With already 51 new molecular entities, or NMEs, getting greenlighted by the FDA so far this year, and still 1 more month to go, 2018 could be a banner year. This outpaces the 53 new drugs approved in 1996 - the highest ever. Read More
The following are some of the pharma/biotech stocks that posted the biggest percentage decline today. Read More
Technology is a double-edged sword, and it is even truer in the case of gene editing, a revolutionary technique that involves inserting, replacing or removing DNA of a human embryo.In this week's "Did you know" column, we bring you news about the world's first gene-edited babies, the top influential films and directors, and the association between cannabis abstinence and memory improvement. Read More
Follow RTT
Economic Calendar
12/09/18 PMI ConstructionNOV Ireland
12/09/18 0:0Eco Watchers Survey; OutlookNOV Japan
12/09/18 0:0Eco Watchers Survey: CurrentNOV Japan
12/08/18 20:30PPI (Y-o-Y)NOV China
12/08/18 20:30CPI (Y-o-Y)NOV China
12/08/18 20:30CPI (M-o-M)NOV China
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/25/19BHC, BHC.TO Loteprednol etabonate ophthalmic gel (NDA)FDA decision on Loteprednol etabonate ophthalmic gel for post-operative inflammation and pain following ocular surgery
02/18/19ALXNALXN1210 (BLA)FDA decision on ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria
02/13/19MTFBIclaprim (NDA)FDA decision on Iclaprim for acute bacterial skin and skin structure infections
02/02/19EOLSDWP-450(Resubmitted BLA)FDA decision on DWP-450 for treatment of moderate to severe glabellar lines
01/31/19ALKSALKS 5461 (NDA)FDA’s final decision on ALKS 5461 for adjunctive treatment of major depressive disorder
View All